Home › MOLDTECH › Filing
🔔 Get instant alerts when MOLDTECH files quarterly results on BSE Start free trial →

Investor Presentation

Filed: 17 Nov 2026, 14:43 IST Exchange: NSE Category: Financial Results — Investor Presentation
Investor Presentation - Q2FY27 - Consolidated revenue ₹60.81 Cr +51.2% y-y; EBITDA ₹14.58 Cr +144.5% y-y (margin 24.0%); PAT ₹9.62 Cr +197.3% y-y (margin 15.8%) - H1 FY27 revenue ₹120.35 Cr +63.7% y-y; EBITDA ₹28.49 Cr +239.1% y-y (margin 23.7%); PAT ₹18.62 Cr +375.1% y-y (margin 15.5%) - FY26-FY28 revenue growth guidance 20-25% CAGR - EBITDA margin target 20%+ and PAT margin 15-16% for FY27-FY28 - Expansion of US Civil & Structural engineering with US$4 Mn work-on-hand and new Beryl platform - Mechanical division repositioned for diversified engineering beyond automotive - New US Electrical Engineering vertical scaling to ~20 engineers targeting US$5-10 Mn annual opportunity
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 MOLDTECH — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add MOLDTECH to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Mold-Tek Technologies Limited

Important. The summary above is generated automatically from Mold-Tek Technologies Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.